ARCHIVES

Partial Responses To Zactima In Thyroid Cancer Trial

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Investigators Present Latest Data On Immunologic Control of Tumors

June 1, 1975

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009

NCI, ACRIN Begin Trial Comparing Digital Mammography To Standard.

September 7, 2001

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

Age-adjusted cancer incidence and mortality down slightly, annual report finds.

June 4, 2004

John & Florence Antione To Leave NCI for Jobs At Loma Linda Univ.

June 21, 1991